ePrints

Precision medicine: the precision gap in rheumatic disease

Lookup NU author(s): Alice Lin, Dr Faye Cooles, Professor John IsaacsORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2022, Springer Nature Limited.For many oncological conditions, the application of timely and patient-tailored targeted therapies, or precision medicine, is a major therapeutic development that has provided considerable clinical benefit. However, despite the application of increasingly sophisticated technologies, alongside advanced bioinformatic and machine-learning algorithms, this success is yet to be replicated for the rheumatic diseases. In rheumatoid arthritis, for example, despite an array of targeted biologic and conventional therapeutics, treatment choice remains largely based on trial and error. The concept of the ‘precision gap’ for rheumatic disease can help us to identify factors that underpin the slow progress towards the discovery and adoption of precision-medicine approaches for rheumatic disease. In a rheumatic disease such as rheumatoid arthritis, it is possible to identify four themes that have slowed progress, solutions to which should help to close the precision gap. These themes relate to our fundamental understanding of disease pathogenesis, how we determine treatment response, confounders of treatment outcomes and trial design.

Publication metadata

Author(s): Lin CMA, Cooles FAH, Isaacs JD

Publication type: Article

Publication status: Published

Journal: Nature Reviews Rheumatology

Year: 2022

Volume: 18

Pages: 725-733

Print publication date: 01/12/2022

Online publication date: 10/10/2022

Acceptance date: 07/09/2022

ISSN (print): 1759-4790

ISSN (electronic): 1759-4804

Publisher: Nature Research

URL: https://doi.org/10.1038/s41584-022-00845-w

DOI: 10.1038/s41584-022-00845-w

PubMed id: 36216923

Altmetrics

Share